Dr. Erika Ruiz-García is the Chief Academic Officer and Head of the Translational Medicine Laboratory at the National Institute of Cancerology (INCan) in Mexico City, where she also serves as a Professor in the Department of Gastrointestinal Medical Oncology. She trained in Medical Oncology at the Hospital de Oncología IMSS Siglo XXI and further specialized in Gastrointestinal Oncology. Her international expertise includes a Fellowship in Translational Research at the Institut Gustave Roussy (France) and a clinical observership at Memorial Sloan Kettering Cancer Center (USA). A prominent figure in the global oncology community, Dr. Ruiz-García is the Educational Program Chair for the ASCO 2026 Annual Meeting. Her leadership history includes serving on the ASCO Gastrointestinal Cancer Guideline Advisory Group and the ESMO Faculty Group of Gastrointestinal Tumors. Currently, she is a member of the ESMO Scientific Committee for Gastrointestinal Tumors (Lower Digestive Tract) for 2026–2027. In Mexico, she is recognized as a Medical Science Researcher Level C by the Ministry of Health. Her prolific academic career includes 114 peer-reviewed articles in prestigious journals . She holds an H-index of 29 with over 3,568 citations and was the Editor of the textbook Translational Research and Onco-Omics Applications (Springer Nature, 2019). Dr. Ruiz-García has secured over $1 million in competitive research funding, serving as the Principal Investigator for Mexico.
Instituto Nacional de Cancerología
Tlalpan, Mexico